Study title: CATAFLAM DROPS (DICLOFENAC RESINATE) IN ACUTE PHARYNGOTONSILLITIS IN CHILDREN, AS AN ADJUVANT TO ANTIBIOTIC THERAPYCATAFLAM DROPS (DICLOFENAC RESINATE) IN ACUTE PHARYNGOTONSILLITIS IN CHILDREN, AS AN ADJUVANT TO ANTIBIOTIC THERAPY
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Anesthesia and Analgesia [E03] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: DICLOFENAC | |||||
ATC code: | |||||
Document link: | |||||
Document date: | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |